Announcements
Drinks
![Scope downgrades VIAN’s issuer rating to BB- from BB and revises the Outlook to Negative](https://www.scopegroup.com/ScopeOneApi/images/announcement-img?imageName=mitteilung_96f102297c63d477f2d5a39f1f1639400f8df351308b5cb5e4eddd8ad416dcaa.jpg)
31/5/2024 Rating announcement EN
Scope downgrades VIAN’s issuer rating to BB- from BB and revises the Outlook to Negative
The downgrade is driven by deteriorating credit metrics due to the demerger and weaker operating performance. The Outlook change reflects uncertainties around the refinancing of the unsecured bonds maturing in November 2024.
![Scope affirms BB rating on Evex Hospitals, with Stable Outlook](https://www.scopegroup.com/ScopeOneApi/images/announcement-img?imageName=mitteilung_7be5327c03865ccf0d6e2e0b59d78bbe1107b276b2f4a27ded315a4f7655ced2.jpg)
8/6/2022 Rating announcement EN
Scope affirms BB rating on Evex Hospitals, with Stable Outlook
The rating affirmation reflects Evex’s resilient operations, cash flow generation and moderate leverage. The rating continues to be constrained by limited scale and high dependence on government-funded revenue streams.
![Scope affirms BB/Stable issuer rating on Evex Hospitals](https://www.scopegroup.com/ScopeOneApi/images/announcement-img?imageName=mitteilung_69b1eb4b828bcb95cf27f84949890345c40a0f563a3e5e8a0110ba2a1cc3f3d0.jpg)
7/7/2021 Rating announcement EN
Scope affirms BB/Stable issuer rating on Evex Hospitals
Scope's rating affirmation reflects Evex's solid operating cash flow generation and conservative liquidity management. The rating continues to be constrained by limited scale and high dependence on government-funded revenue streams.
![Scope assigns initial issuer rating of BB to Georgian JSC Evex Hospitals, with a Stable Outlook](https://www.scopegroup.com/ScopeOneApi/images/announcement-img?imageName=mitteilung_44e471f9b6aa154a7fb6f6035fa2cb8332d20d32d2e9b45e6e66b1c822154026.jpg)
11/7/2019 Rating announcement EN
Scope assigns initial issuer rating of BB to Georgian JSC Evex Hospitals, with a Stable Outlook
The credit-positive characteristics of the healthcare services market, the company’s strong operating profitability and market shares in Georgia, and Scope’s expectation of a rapid improvement in financial metrics equally support the ratings.